sarcosine has been researched along with Colorectal Cancer in 9 studies
cocobetaine: N-alkyl-betaine; cause of shampoo dermatitis
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC), to investigate plasma concentrations of the methyl donors methionine, choline, betaine (trimethylglycine), and dimethylglycine (DMG) in relation to colorectal cancer (CRC) risk." | 7.80 | Plasma methionine, choline, betaine, and dimethylglycine in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). ( Argüelles, M; Bamia, C; Barricarte, A; Bjørge, T; Boutron-Ruault, M; Bueno-de-Mesquita, HB; Cottet, V; de Vogel, S; Dorronsoro, M; Duarte-Salles, T; Eussen, SJ; Freisling, H; Grioni, S; Gunter, MJ; Hansen, L; Huerta, JM; Jakszyn, P; Johansson, M; Kaaks, R; Khaw, K; Kühn, T; Ljuslinder, I; Meyer, K; Naska, A; Nitter, M; Norgård, B; Nygård, O; Palli, D; Panico, S; Peeters, PH; Racine, A; Riboli, E; Sánchez, M; Stepien, M; Tjønneland, A; Trichopoulou, A; Tumino, R; Ueland, PM; Ulvik, A; van Kranen, H; Vineis, P; Vollset, SE; Wareham, N; Weiderpass, E, 2014) |
| "Liquid nitrogen storage can stop the metabolic process of glucose and choline phospholipid in colorectal cancer tissue samples in vitro, thus maintaining the metabolic state of tissue samples in vivo as much as possible." | 4.12 | Pretreatment optimization of tissue metabolomics in colorectal cancer. ( Deng, P; Han, Y; Huang, H; Jiang, H; Liang, H; Liu, H; Lu, CD; Peng, J; Wang, L; Wang, Y; Yang, G, 2022) |
| "Higher plasma concentrations of methionine and betaine were associated with modest colorectal cancer risk reductions (OR [95% confidence interval {CI}] for highest versus lowest tertile: 0." | 3.83 | Components of One-carbon Metabolism Other than Folate and Colorectal Cancer Risk. ( Gylling, B; Häggström, J; Hallmans, G; Hultdin, J; Johansson, I; Myte, R; Palmqvist, R; Schneede, J; Ueland, PM; Van Guelpen, B, 2016) |
| "We conducted a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC), to investigate plasma concentrations of the methyl donors methionine, choline, betaine (trimethylglycine), and dimethylglycine (DMG) in relation to colorectal cancer (CRC) risk." | 3.80 | Plasma methionine, choline, betaine, and dimethylglycine in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). ( Argüelles, M; Bamia, C; Barricarte, A; Bjørge, T; Boutron-Ruault, M; Bueno-de-Mesquita, HB; Cottet, V; de Vogel, S; Dorronsoro, M; Duarte-Salles, T; Eussen, SJ; Freisling, H; Grioni, S; Gunter, MJ; Hansen, L; Huerta, JM; Jakszyn, P; Johansson, M; Kaaks, R; Khaw, K; Kühn, T; Ljuslinder, I; Meyer, K; Naska, A; Nitter, M; Norgård, B; Nygård, O; Palli, D; Panico, S; Peeters, PH; Racine, A; Riboli, E; Sánchez, M; Stepien, M; Tjønneland, A; Trichopoulou, A; Tumino, R; Ueland, PM; Ulvik, A; van Kranen, H; Vineis, P; Vollset, SE; Wareham, N; Weiderpass, E, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, H | 1 |
| Wang, Y | 1 |
| Han, Y | 1 |
| Yang, G | 1 |
| Wang, L | 1 |
| Peng, J | 1 |
| Lu, CD | 1 |
| Deng, P | 1 |
| Liang, H | 1 |
| Huang, H | 1 |
| Jiang, H | 1 |
| Guo, J | 1 |
| Pan, Y | 1 |
| Chen, J | 1 |
| Jin, P | 1 |
| Tang, S | 1 |
| Wang, H | 1 |
| Su, H | 1 |
| Wang, Q | 1 |
| Chen, C | 1 |
| Xiong, F | 1 |
| Liu, K | 1 |
| Li, Y | 1 |
| Su, M | 1 |
| Tang, T | 1 |
| He, Y | 1 |
| Sheng, J | 1 |
| Yang, Y | 1 |
| Wang, Z | 1 |
| Li, X | 1 |
| Lv, J | 1 |
| Zhong, R | 1 |
| Gao, S | 1 |
| Zhang, F | 1 |
| Chen, W | 1 |
| Prasher, P | 1 |
| Sharma, M | 1 |
| Lee, CH | 1 |
| Lin, YF | 1 |
| Chen, YC | 1 |
| Wong, SM | 1 |
| Juan, SH | 1 |
| Huang, HM | 1 |
| Pundir, CS | 1 |
| Deswal, R | 1 |
| Kumar, P | 1 |
| Nitter, M | 1 |
| Norgård, B | 1 |
| de Vogel, S | 1 |
| Eussen, SJ | 1 |
| Meyer, K | 1 |
| Ulvik, A | 1 |
| Ueland, PM | 2 |
| Nygård, O | 1 |
| Vollset, SE | 1 |
| Bjørge, T | 1 |
| Tjønneland, A | 1 |
| Hansen, L | 1 |
| Boutron-Ruault, M | 1 |
| Racine, A | 1 |
| Cottet, V | 1 |
| Kaaks, R | 1 |
| Kühn, T | 1 |
| Trichopoulou, A | 1 |
| Bamia, C | 1 |
| Naska, A | 1 |
| Grioni, S | 1 |
| Palli, D | 1 |
| Panico, S | 1 |
| Tumino, R | 1 |
| Vineis, P | 1 |
| Bueno-de-Mesquita, HB | 1 |
| van Kranen, H | 1 |
| Peeters, PH | 1 |
| Weiderpass, E | 1 |
| Dorronsoro, M | 1 |
| Jakszyn, P | 1 |
| Sánchez, M | 1 |
| Argüelles, M | 1 |
| Huerta, JM | 1 |
| Barricarte, A | 1 |
| Johansson, M | 1 |
| Ljuslinder, I | 1 |
| Khaw, K | 1 |
| Wareham, N | 1 |
| Freisling, H | 1 |
| Duarte-Salles, T | 1 |
| Stepien, M | 1 |
| Gunter, MJ | 1 |
| Riboli, E | 1 |
| Myte, R | 1 |
| Gylling, B | 1 |
| Schneede, J | 1 |
| Häggström, J | 1 |
| Hultdin, J | 1 |
| Hallmans, G | 1 |
| Johansson, I | 1 |
| Palmqvist, R | 1 |
| Van Guelpen, B | 1 |
| Yoshie, T | 1 |
| Nishiumi, S | 1 |
| Izumi, Y | 1 |
| Sakai, A | 1 |
| Inoue, J | 1 |
| Azuma, T | 1 |
| Yoshida, M | 1 |
1 review available for sarcosine and Colorectal Cancer
| Article | Year |
|---|---|
Quantitative analysis of sarcosine with special emphasis on biosensors: a review.
Topics: Alzheimer Disease; Amino Acid Metabolism, Inborn Errors; Biomarkers; Biosensing Techniques; Colorect | 2019 |
8 other studies available for sarcosine and Colorectal Cancer
| Article | Year |
|---|---|
Pretreatment optimization of tissue metabolomics in colorectal cancer.
Topics: Choline; Colorectal Neoplasms; Creatine; Glucose; Glycerylphosphorylcholine; Humans; Lactates; Nitro | 2022 |
Serum metabolite signatures in normal individuals and patients with colorectal adenoma or colorectal cancer using UPLC-MS/MS method.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Acetylglucosamine; Adenocarcinoma; Adenoma; Chenodeoxych | 2023 |
Profiling the metabolic disorder and detection of colorectal cancer based on targeted amino acids metabolomics.
Topics: Amino Acids; Biomarkers, Tumor; Colorectal Neoplasms; Glutamates; Humans; Metabolomics; Sarcosine; T | 2023 |
Topics: Adenocarcinoma; Amides; Antineoplastic Agents; Colorectal Neoplasms; Enzyme Inhibitors; Humans; N-Ac | 2020 |
MPT0B169 and MPT0B002, New Tubulin Inhibitors, Induce Growth Inhibition, G2/M Cell Cycle Arrest, and Apoptosis in Human Colorectal Cancer Cells.
Topics: Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; G2 Phas | 2018 |
Plasma methionine, choline, betaine, and dimethylglycine in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Topics: Aged; Betaine; Case-Control Studies; Choline; Colorectal Neoplasms; Europe; Female; Humans; Male; Me | 2014 |
Components of One-carbon Metabolism Other than Folate and Colorectal Cancer Risk.
Topics: Aged; Amino Acids; Betaine; Biomarkers; Biomarkers, Tumor; Case-Control Studies; Choline; Colorectal | 2016 |
Regulation of the metabolite profile by an APC gene mutation in colorectal cancer.
Topics: Adenomatous Polyposis Coli Protein; Amino Acids; Animals; Cell Line, Tumor; Citric Acid Cycle; Color | 2012 |